Is hyperoxia harmful in ICU patients?  Does a restrictive approach to prescription of FiO2 in ventilated patients improve patient centred outcomes?

These questions have led to the ICU-ROX trial, which was recently released at the World Congress of Intensive Care in Melbourne, Australia.  Principle investigator Dr Paul Young presented the paper, and joins Todd on the podcast to discuss the results, and where we go from here.

See omnystudio.com/listener for privacy information.